Data on their combined use is also lacking, as there is only a single preliminary study suggesting BPC-157 enhances growth hormone receptor expression
Researchers raise doses in animals until roughly 50% die, giving a crude measure of acute lethality that does not translate directly to human safety but gives context for risk margins
This is not a claim that peptide therapy replaces HRT, PCOS management, or standard metabolic care
Common signs include: Fatigue and weakness Numbness or tingling in the hands and feet Difficulty walking or balance problems Mood changes, such as depression or anxiety Cognitive difficulties, including memory loss or confusion If not treated, a B12 deficiency can cause serious problems
Body weight affects dosing
At our clinic in Doral, FL, we explain this distinction clearly at the start of every tesamorelin protocol